Oncology Clinical Trials in San Francisco, CA

As of September 2026, 257 paid clinical trials are recruiting for Oncology in San Francisco, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in San Francisco

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities

for Prostate Cancer

1 location in San Francisco

Sponsor: University of California, San Francisco

Sex: Male·Age: 18+

Code: NCT07690579·Recruiting·Listed Jul 8, 2026

Apply to this trial

258 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in San Francisco, CA.

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for Solid Tumors

Drug: INCB161734

Sites in San Francisco, Santa Monica +68 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07522073·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

Drug: PF-08634404

Sites in San Francisco, San Mateo +198 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Cancer

Drug: daraxonrasib

Sites in San Francisco, Palo Alto +33 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Sites in San Francisco, Los Angeles +37 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in San Francisco, Santa Monica +41 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for Breast Neoplasms

Sites in San Francisco, Emeryville +123 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

Sites in San Francisco, Sacramento +89 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

Sites in San Francisco, San Mateo +170 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

for Non-small Cell Lung Cancer

Drug: Zongertinib

Sites in San Francisco, Vallejo +25 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for Endometrial Cancer

Sites in San Francisco, Irvine +60 more locations

Sponsor: Genmab

Sex: Female·Age: 18+

Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for Carcinoma, Non-Small-Cell Lung

Drug: Amivantamab

Sites in San Francisco, Vallejo +123 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for Urothelial Carcinoma

Sites in San Francisco, Templeton +141 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04879329·Phase 2·Recruiting·Listed May 2021

Apply to this trial

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

Sites in San Francisco, Berkeley +122 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

Sites in San Francisco, Berkeley +59 more locations

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

Sites in San Francisco, Palo Alto +40 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for Breast Cancer

Sites in San Francisco, Palo Alto +47 more locations

Sponsor: Greenwich LifeSciences, Inc.

Sex: All·Age: 18 - 100

Code: NCT05232916·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for Chronic Lymphocytic Leukemia

Sites in San Francisco, Oakland +44 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06973187·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for PIK3CA Mutation

Sites in San Francisco, Vallejo +50 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06982521·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for Epithelial Ovarian Cancer

Sites in San Francisco, Los Angeles +65 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT06890338·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for Neoplasms

Sites in San Francisco, Stanford +76 more locations

Sponsor: Celgene

Sex: All·Age: All ages

Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018

Apply to this trial

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for Diffuse Large B-Cell Lymphoma

Drug: Rituximab

Sites in San Francisco, Los Angeles +45 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06717347·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for Multiple Myeloma

Sites in San Francisco, Stanford +26 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05201781·Phase 4·Recruiting·Listed Jan 2022

Apply to this trial

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for Glioma

Sites in San Francisco, Palo Alto +44 more locations

Sponsor: Nuvation Bio Inc.

Sex: All·Age: 18+

Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022

Apply to this trial

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for Carcinoma, Non-Small-Cell Lung

Drug: Intismeran autogene

Sites in San Francisco, Los Angeles +48 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for Non-Small Cell Lung Cancer

Drug: Divarasib

Sites in San Francisco, Palo Alto +52 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

for Melanoma

Sites in San Francisco, Santa Monica +56 more locations

Sponsor: Pfizer

Sex: All·Age: 16+

Code: NCT05538130·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for Ovarian Cancer

Sites in San Francisco, Walnut Creek +33 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06824467·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for Non Small Cell Lung Cancer

Sites in San Francisco, Beverly Hills +42 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06312137·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for Prostate Cancer

Sites in San Francisco, Duarte +19 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT04221542·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in San Francisco, Los Alamitos +44 more locations

Sponsor: Celgene

Sex: Male·Age: 18+

Code: NCT06764485·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for Cancer

Sites in San Francisco, Palo Alto +28 more locations

Sponsor: Parabilis Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05919264·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for Hormone Receptor Positive HER-2 Negative Breast Cancer

Sites in San Francisco, Beverly Hills +32 more locations

Sponsor: Puma Biotechnology, Inc.

Sex: All·Age: 18+

Code: NCT06369285·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for Advanced Breast Cancer

Sites in San Francisco, Palo Alto +35 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06638307·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for AML

Sites in San Francisco, Los Angeles +34 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

for Non-small Cell Lung Cancer

Drug: Relatlimab

Sites in San Francisco, Sacramento +38 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06561386·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for Prostate Cancer

Drug: JANX007

Sites in San Francisco, Sacramento +31 more locations

Sponsor: Janux Therapeutics

Sex: Male·Age: 18 - 100

Code: NCT05519449·Phase 1·Recruiting·Listed Aug 2022

Apply to this trial

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

for Brain Tumor, Recurrent

Sites in San Francisco, Castro Valley +49 more locations

Sponsor: GT Medical Technologies, Inc.

Sex: All·Age: All ages

Code: NCT04427384·Recruiting·Listed Jun 2020

Apply to this trial

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for Acute Leukemia

Sites in San Francisco, Duarte +20 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 2+

Code: NCT04811560·Phase 1, Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for Cancer Harboring BRAF Alterations

Sites in San Francisco, Beverly Hills +27 more locations

Sponsor: Fore Biotherapeutics

Sex: All·Age: 8+

Code: NCT05503797·Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for Small Cell Lung Cancer

Sites in San Francisco, Los Angeles +28 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06203210·Phase 3·Recruiting·Listed Jan 2024

Apply to this trial

Top Research Study Locations in San Francisco

Researchers run research studies in San Francisco, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
University of California, San Francisco	Prostate Cancer, Glioblastoma, Epilepsy	320
University of California San Francisco	Prostate Cancer, Breast Cancer, Multiple Myeloma	166
Power Life Sciences	Acne, Anorexia, Anorexia Nervosa	51
UCSF	Colorectal Cancer, ADHD, ALK-Positive Lung Cancer	32
Kaiser Permanente-San Francisco	Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma	32
UCSF Medical Center-Mission Bay	B Acute Lymphoblastic Leukemia, Neuroblastoma, Acute Myeloid Leukemia	32
Zuckerberg San Francisco General Hospital	Cardiovascular Diseases, HIV, Healthy	26
UCSF Medical Center	Stroke, Aneurysm, Aneurysm, Intracranial	23
California Pacific Medical Center-Pacific Campus	Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma	22
UCSF Helen Diller Family Comprehensive Cancer Center	Advanced Breast Cancer, Breast Cancer, Solid Tumor, Adult	21
University of California	Aortic Valve Regurgitation, Aortic Valve Stenosis, Articular Cartilage	18
San Francisco VA Medical Center, San Francisco, CA	PTSD, Sleep Initiation and Maintenance Disorders, Aging	16
University of California, San Francisco (UCSF)	Colorectal Cancer, Non-small Cell Lung Cancer, Acquired Resistance to KRAS G12C Inhibitor	15
UCSF Benioff Children's Hospital	4H Syndrome, ADLD, AGS	14
California Pacific Medical Center	Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Melanoma	12
San Francisco General Hospital	HIV, HIV Infections, Intracerebral Hemorrhage	12
San Francisco Research Institute	Women Health, Anxiety, Cognitive Decline	10
Alethios, Inc.	Abdominal Discomfort, Digestive Health, Digestive Well Being	9
San Francisco VA Medical Center	Atopic Dermatitis, Eczema, Atopic Dermatitis (Eczema)	9
UCSF Medical Center-Parnassus	Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy	8
University of California - San Francisco	Diabetes, Diabetic Foot, Diabetic Foot Ulcer	8
University of California San Francisco (UCSF)	Melanoma, Advanced Solid Tumors, Angiosarcoma	8
University of California at San Francisco	Advanced Tumors, Aortic Valve Disease, Aortic Valve Stenosis	8
University of San Francisco	Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease	7
UCSF Medical Center at Mission Bay	Breast Cancer, Atrial Fibrillation (AF), Atrial Fibrillation (Paroxysmal)	6

Active & Upcoming Studies in San Francisco (2026)

Recruiting trials in San Francisco grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Common conditions studied in San Francisco

Breast Cancer (28 active studies)
Prostate Cancer (27 active studies)
Heart Failure (18 active studies)
HIV (16 active studies)
Cancer (13 active studies)
Solid Tumor (13 active studies)

Leading research sponsors in San Francisco

University of California, San Francisco
Power Life Sciences Inc.
National Cancer Institute (NCI)
AstraZeneca
Children's Oncology Group

Frequently asked questions

How many paid clinical trials are currently recruiting in San Francisco?

There are approximately 1,349 recruiting clinical trials in San Francisco, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in San Francisco pay participants?

Most recruiting trials in San Francisco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in San Francisco?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in San Francisco?

The most common conditions under active study in San Francisco include Breast Cancer (28), Prostate Cancer (27), Heart Failure (18), HIV (16), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in San Francisco?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in San Francisco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in San Francisco?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in San Francisco?

Recruiting research sites in San Francisco include University of California, San Francisco, University of California San Francisco, Power Life Sciences, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in San Francisco right now?

The largest active categories in San Francisco are Cancer & tumors (396), Neurology & pain (83), Cardiovascular (82). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in California

Los Angeles, CA(1,970)San Diego, CA(754)Palo Alto, CA(655)Sacramento, CA(588)Duarte, CA(548)La Jolla, CA(534)Orange, CA(511)Stanford, CA(426)Irvine, CA(380)Long Beach, CA(203)Newport Beach, CA(186)Santa Monica, CA(183)Walnut Creek, CA(182)Beverly Hills, CA(170)Oakland, CA(169)Torrance, CA(164)Loma Linda, CA(161)Anaheim, CA(126)Santa Rosa, CA(107)Fresno, CA(105)Pasadena, CA(102)Redwood City, CA(97)Fountain Valley, CA(95)Fullerton, CA(95)Glendale, CA(95)Lancaster, CA(89)Riverside, CA(86)Fremont, CA(80)Los Alamitos, CA(80)San Jose, CA(77)Huntington Beach, CA(76)Roseville, CA(70)Santa Barbara, CA(70)Vallejo, CA(66)Modesto, CA(64)Bakersfield, CA(63)Thousand Oaks, CA(62)Chula Vista, CA(58)Northridge, CA(58)Upland, CA(58)Burbank, CA(56)Berkeley, CA(55)Garden Grove, CA(49)Oceanside, CA(49)Santa Ana, CA(49)Stockton, CA(48)Santa Clara, CA(47)Pomona, CA(46)Bellflower, CA(43)San Leandro, CA(43)Santa Maria, CA(43)Tarzana, CA(42)Davis, CA(41)Downey, CA(41)San Luis Obispo, CA(41)Arroyo Grande, CA(40)San Rafael, CA(40)Oxnard, CA(39)La Mesa, CA(38)West Hills, CA(37)

Related healthcare resources in California

Latest San Francisco, CA clinical trials research report

Trials by condition in San Francisco

Breast Cancer· 28 Prostate Cancer· 27 Heart Failure· 18 HIV· 16 Glioblastoma· 12 Acute Myeloid Leukemia· 11

Conditions in Oncology (San Francisco, CA)

Solid tumor· 47 Prostate cancer· 32 Breast cancer· 30 Non-small cell lung cancer (NSCLC)· 26 Cancer (any)· 18 Metastatic prostate cancer· 16 Glioblastoma· 16 Metastatic breast cancer· 14 Colorectal cancer· 14 Bladder cancer· 12 Acute myeloid leukemia (AML)· 12 Melanoma· 12 Pancreatic cancer· 11 Ovarian cancer· 11 Multiple myeloma· 10 Non-Hodgkin lymphoma· 10 Endometrial cancer· 8 Liver cancer· 7 Glioma· 7 Hematologic malignancy· 7 Neuroblastoma· 7 Pediatric cancer· 7 Kidney cancer· 6 Brain cancer· 6 Leukemia (other)· 6 Triple-negative breast cancer· 5 Myelodysplastic syndromes (MDS)· 5 Follicular lymphoma· 5 HER2-negative breast cancer· 4 Fallopian tube cancer· 4 Diffuse large B-cell lymphoma (DLBCL)· 4 Mantle cell lymphoma· 4 Head and neck cancer· 4 Neuroendocrine tumors· 4 Lung cancer· 3 Gastric cancer· 3 Biliary tract cancer· 3 Cervical cancer· 3 Gynecologic cancer· 3 Small lymphocytic lymphoma· 3 Thyroid cancer· 3 HER2-positive breast cancer· 2 Colon cancer· 2 Uterine cancer· 2 Chronic lymphocytic leukemia (CLL)· 2 Acute lymphoblastic leukemia· 2 Myelofibrosis· 2 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Osteosarcoma· 2 Ewing sarcoma· 2 Rhabdomyosarcoma· 2 Small cell lung cancer· 1 Metastatic colorectal cancer· 1 Gastroesophageal junction cancer· 1 Gastrointestinal cancer· 1 Brain metastases· 1 Marginal zone lymphoma· 1 Burkitt lymphoma· 1 Sarcoma· 1 Soft tissue sarcoma· 1 Mesothelioma· 1

Oncology Clinical Trials in San Francisco, CA

Newly added in San Francisco

258 clinical trials for Oncology

Top Research Study Locations in San Francisco

Active & Upcoming Studies in San Francisco (2026)

Cancer & tumors (396 active studies)

Neurology & pain (83 active studies)

Cardiovascular (82 active studies)

Mental health & behavior (49 active studies)

HIV / STI (48 active studies)

Diabetes & metabolic (37 active studies)

Pediatric (21 active studies)

Eye & vision (19 active studies)

Vaccines (13 active studies)

Common conditions studied in San Francisco

Leading research sponsors in San Francisco

Frequently asked questions

How many paid clinical trials are currently recruiting in San Francisco?

Do clinical trials in San Francisco pay participants?

Who can participate in a clinical trial in San Francisco?

What conditions are most commonly studied in San Francisco?

Are there clinical trials for healthy volunteers in San Francisco?

How do I enroll in a clinical trial in San Francisco?

Where can I take part in paid clinical trials in San Francisco?

What kinds of studies are recruiting in San Francisco right now?

Browse more clinical trials

Other cities in California

Related healthcare resources in California

Trials by condition in San Francisco

Conditions in Oncology (San Francisco, CA)